APPRISE COVID-19 publications and presentations

APPRISE researchers have co-authored or presented the following publications and presentations related to the COVID-19 pandemic

• Evaluation of the Australian first few X household transmission project for COVID-19
• “You can’t replace that feeling of connection to culture and country”: Aboriginal and Torres Strait Islander Parents’ experiences of the COVID-19 pandemic
• Anticoagulation strategies in non–critically ill patients with Covid-19
• Key features of a trauma-informed public health emergency approach: A rapid review
• A culturally responsive trauma-informed public health emergency framework for Aboriginal and Torres Strait Islander Communities in Australia, developed during COVID-19
• Key lessons from the COVID-19 public health response in Australia
• An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
• Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: A structured, narrative review
• ISARIC-COVID-19 dataset: A prospective, standardized, global dataset of patients hospitalized with COVID-19
• Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
• Exploring healthcare workers’ perspectives of video feedback for training in the use of powered air purifying respirators (PAPR) at the onset of the COVID-19 pandemic
• ‘Like building a plane and flying it all in one go’: an interview study of infection prevention and control in Australian general practice during the first 2 years of the SARS-CoV-2 pandemic
• Learnings from the Australian first few X household transmission project for COVID-19
• Engage, understand, listen and act: evaluation of Community Panels to privilege First Nations voices in pandemic planning and response in Australia
• Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020
• Virology and immune dynamics reveal high household transmission of ancestral SARS-CoV-2 strain
• Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection [preprint]
• Transmission of SARS-CoV-2 in standardised first few X cases and household transmission investigations: A systematic review and meta-analysis
• People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in Australia
• Paradoxes of pandemic infection control: Proximity, pace and care within and beyond SARS-CoV-2
• Experiences of risk in Australian hotel quarantine: a qualitative study
• Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol
• Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: A randomized clinical trial
• Transmission of SARS-CoV-2 in standardised First Few X cases and household transmission investigations: a systematic review and meta-analysis [preprint]
• What is needed to sustain improvements in hospital practices post-COVID-19? A qualitative study of interprofessional dissonance in hospital infection prevention and control
• The ongoing value of first few X studies for COVID-19 in the Western Pacific Region
• COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2
• Rapid assessment of the risk of SARS-CoV-2 importation: case study and lessons learned
• The Burden of the Beast. Countering conspiracies and misinformation within Indigenous communities in Australia
• Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-specific antibodies in Australia after the first epidemic wave in 2020: A national survey
• Effectiveness evaluation of digital contact tracing for COVID-19 in New South Wales, Australia
• A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
• Experiences of the SARS-CoV-2 pandemic amongst Australian Healthcare workers: From stressors to protective factors
• Glucocorticoid dose in COVID-19: Lessons for clinical trials during a pandemic
• “One minute it’s an airborne virus, then it’s a droplet virus, and then it’s like nobody really knows…”: Experiences of pandemic PPE amongst Australian healthcare workers
• The value of open-source clinical science in pandemic response: lessons from ISARIC
• Understanding how Victoria, Australia gained control of its second COVID-19 wave
• Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19. A randomized clinical trial
• Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
• Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study
• Doherty Modelling–Final report to National Cabinet 5th November 2021
• Respiratory virus detection during the COVID-19 pandemic in Queensland, Australia
• ATAGI 2021 annual statement on immunisation Last updated: 19 September 2021
• Decision-making for pandemics: an ethics framework
• Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection
• Policy considerations for mandatory COVID-19 vaccination from the Collaboration on Social Science in Immunisation
• Modelling testing and response strategies for COVID-19 outbreaks in remote Australian Aboriginal communities
• Essential Emergency and Critical Care: a consensus among global clinical experts
• Entanglements of affect, space, and evidence in pandemic healthcare: An analysis of Australian healthcare workers’ experiences of COVID-19
• Optimal allocation of PCR tests to minimise disease transmission through contact tracing and quarantine
• Doherty Modelling Interim Report to National Cabinet 17th September 2021
• Therapeutic anticoagulation with heparin in critically ill patients with Covid-19
• Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
• Doherty Modelling Report Revised 10th August 2021
• Doherty Modelling Report for National Cabinet 30 July 2021
• Leading with local solutions to keep Yarrabah safe: a grounded theory study of an Aboriginal community-controlled health organisation’s response to COVID-19
• The impact of the COVID‐19 pandemic on routine vaccinations in Victoria
• Australia needs a prioritised national research strategy for clinical trials in a pandemic: lessons learned from COVID-19
• Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
• An increased ratio of SARS-CoV-2 positive to negative sense genomic and subgenomic RNAs within routine diagnostic upper respiratory tract swabs may be a marker of virion shedding [preprint]
• Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia
• Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19)
• Evaluation of 6 commercial SARS-CoV-2 serology assays detecting different antibodies for clinical testing and serosurveillance
• COVID‐19 Real‐time Information System for Preparedness and Epidemic Response (CRISPER)
• Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study
• Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
• Interleukin-6 receptor antagonists in critically ill patients with Covid-19
• Value of consultation in establishing a public health research network: lessons from APPRISE
• Education and training in infection prevention and control: Exploring support for national standards
• How should we conduct pandemic vaccination?
• Constructing an ethical framework for priority allocation of pandemic vaccines
• How do data bolster pandemic preparedness and response? How do we improve data and systems to be better prepared?
• Hospital outcomes after a COVID-19 diagnosis from January to May 2020 in New South Wales Australia
• Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
• Priority allocation of pandemic influenza vaccines in Australia – Recommendations of 3 community juries.
• Maintaining strong foundations and building resilience: planning Australia’s path through the COVID-19 pandemic
• Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020
• COVID-19 public health measures and respiratory syncytial virus
• SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication
• Changes in public preferences for technologically enhanced surveillance following the COVID-19 pandemic: a discrete choice experiment
• Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020
• Ending COVID-19: progress and gaps in research—highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings
• Leveraging the advances in HIV for COVID-19
• Coronavirus disease model to inform transmission reducing measures and health system preparedness, Australia
• COVID‐19 in a Sydney nursing home: a case study and lessons learnt
• Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19. The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
• Tracking the COVID-19 pandemic in Australia using genomics
• Building an ethics framework for COVID-19 resource allocation: The How and the Why
• An ethics framework for making resource allocation decisions within clinical care: Responding to COVID-19
• Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
• RDA COVID-19 Working Group recommendations and guidelines on data sharing
• Webinar: Bioethics and COVID-19
• The challenges of establishing adequate capacity for SARS‐CoV‐2 testing
• Isolation and rapid sharing of the 2019 novel coronavirus (SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Australia
• Rapid research report – The most promising therapeutics for COVID-19
• Trajectories of hospital infection control: Using non-representational theory to understand and improve infection prevention and control
• Estimating temporal variation in transmission of COVID-19 and adherence to social distancing measures in Australia [technical report]
• Key ethical concepts and their application to COVID-19 research
• First Nations people leading the way in COVID-19 pandemic planning, response and management
• Estimating the case detection rate and temporal variation in transmission of COVID-19 in Australia [technical report]
• Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness [pre-print]
• Early analysis of the Australian COVID-19 epidemic
• Early analysis of the Australian COVID-19 epidemic [pre-print]
• Assessing the risk of spread of COVID-19 to the Asia Pacific region
• SARS, MERS and COVID-19—new threats; old lessons
• Living with COVID-19: Planning policy for the next stage
• Infectious disease pandemic planning and response: Incorporating decision analysis
• An ethics framework for making resource allocation decisions within clinical care: Responding to COVID-19
• Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19